VILTEPSO

PeakRNA

viltolarsen

Nippon Shinyaku
NDAINTRAVENOUSSOLUTIONPriority Review
Approved
Aug 2020
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Apr 3, 2034
98 months away
Patent Expiry
Apr 3, 2034
Exclusivity Expiry
Aug 12, 2027

Patent Records (2)

Patent #ExpiryTypeUse Code
10870676
Aug 31, 2031
SubstanceProduct
U-3039
9079934
Apr 3, 2034
SubstanceProduct
—
Company
NS
Nippon Shinyaku
Japan - Kyoto
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers